Obama Touts Generic Biologics To Lower Drug Costs

Law360, New York (February 26, 2009, 12:00 AM EST) -- In an effort to cut down prescription drug costs for both private citizens and the federal government, President Obama is pushing for the creation of a pathway to get generic biologic drugs to the market.

In the opening remarks of his budget, the president said that the ideal mechanism would be modeled on the 1984 Hatch-Waxman Act, which allows generic drug companies to provide bioequivalence studies to the U.S. Food and Drug Administration rather than perform costly and time-consuming clinical trials but also provides exclusivity periods...
To view the full article, register now.